Screening for Hepatitis C Virus Infection in Adolescents and Adults US Preventive Services Task Force Recommendation Statement

被引:200
作者
Owens D.K. [1 ,2 ]
Davidson K.W. [3 ]
Krist A.H. [4 ,5 ]
Barry M.J. [6 ]
Cabana M. [7 ]
Caughey A.B. [8 ]
Donahue K. [9 ]
Doubeni C.A. [10 ]
Epling J.W. [11 ]
Kubik M. [12 ]
Ogedegbe G. [13 ]
Pbert L. [14 ]
Silverstein M. [15 ]
Simon M.A. [16 ]
Tseng C.-W. [17 ,18 ]
Wong J.B. [19 ]
机构
[1] Veterans Affairs Palo Alto Health Care System, Palo Alto, CA
[2] Stanford University, Stanford, CA
[3] Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY
[4] Fairfax Family Practice Residency, Fairfax, VA
[5] Virginia Commonwealth University, Richmond
[6] Harvard Medical School, Boston, MA
[7] University of California, San Francisco
[8] Oregon Health and Science University, Portland
[9] Mayo Clinic, Rochester, MN
[10] Virginia Tech Carilion School of Medicine, Roanoke
[11] Temple University, Philadelphia, PA
[12] New York University, New York, NY
[13] University of Massachusetts Medical School, Worcester
[14] Boston University, Boston, MA
[15] Northwestern University, Evanston, IL
[16] University of Hawaii, Honolulu
[17] Pacific Health Research and Education Institute, Honolulu, HI
[18] Tufts University School of Medicine, Boston, MA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 323卷 / 10期
关键词
UNITED-STATES; TRANSMISSION; PREVALENCE; WOMEN; RISK; HCV;
D O I
10.1001/jama.2020.1123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This 2020 Recommendation Statement from the US Preventive Services Task Force recommends screening for hepatitis C virus infection in adults aged 18 to 79 years (B recommendation). Importance Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance. Objective To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on screening for HCV infection in adolescents and adults. Population This recommendation applies to all asymptomatic adults aged 18 to 79 years without known liver disease. Evidence Assessment The USPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 years has substantial net benefit. Recommendation The USPSTF recommends screening for HCV infection in adults aged 18 to 79 years. (B recommendation)
引用
收藏
页码:970 / 975
页数:6
相关论文
共 27 条
  • [1] Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
    Ghany M.G.
    Morgan T.R.
    [J]. HEPATOLOGY, 2020, 71 (02) : 686 - 721
  • [2] American Association for the Study of Liver Diseases Infectious Diseases Society of America, INF DIS SOC AM HCV T
  • [3] [Anonymous], AHRQ PUBLICATION
  • [4] [Anonymous], 2007, OBSTET GYNECOL
  • [5] [Anonymous], 2018, PROC MAN
  • [6] Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States
    Barocas, Joshua A.
    Tasillo, Abriana
    Yazdi, Golnaz Eftekhari
    Wang, Jianing
    Vellozzi, Claudia
    Hariri, Susan
    Isenhour, Cheryl
    Randall, Liisa
    Ward, John W.
    Mermin, Jonathan
    Salomon, Joshua A.
    Linas, Benjamin P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 67 (04) : 549 - 556
  • [7] Centers for disease control and Prevention, TEST REC HEP C VIR I
  • [8] Centers for Disease Control and Prevention, CDC REC HEP C SCREEN
  • [9] Centers for Disease Control and Prevention, 2017, HEP C QUEST ANSW HLT
  • [10] Centers for Disease Control and Prevention (CDC), 2019, SURV VIR HEP US